We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$11.9B
AUM Growth
+$1.64B
Cap. Flow
+$3.17B
Cap. Flow %
26.56%
Top 10 Hldgs %
6.6%
Holding
3,409
New
939
Increased
912
Reduced
776
Closed
491

Sector Composition

Rank Sector Weight
1 Financials 22.64%
2 Technology 16.18%
3 Consumer Discretionary 11.16%
4 Industrials 10.33%
5 Healthcare 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOUN icon
2601
SoundHound AI
SOUN
$3.49B
$71K ﹤0.01%
21,600
+6,800
+46% +$22.8K
CAMP
2602
DELISTED
CalAmp Corp.
CAMP
$71K ﹤0.01%
+800
New +$91K
BBIG
2603
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$71K ﹤0.01%
+3,830
New +$76.2K
RIDE
2604
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$71K ﹤0.01%
+2,587
New +$82.4K
IMTXW
2605
DELISTED
Immatics N.V. Warrants
IMTXW
$68K ﹤0.01%
25,250
STSA
2606
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$68K ﹤0.01%
11,300
-100
-0.9% -$567
RDW icon
2607
Redwire
RDW
$3.25B
$67K ﹤0.01%
27,700
-13,700
-33% -$42.3K
AMRX icon
2608
Amneal Pharmaceuticals
AMRX
$5.79B
$65K ﹤0.01%
+32,352
New +$90.7K
TV icon
2609
Televisa
TV
$1.49B
$64K ﹤0.01%
+12,000
New +$84.2K
TCRR
2610
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$64K ﹤0.01%
35,400
-29,000
-45% -$84.1K
OPTU
2611
Optimum Communications Inc
OPTU
$301M
$63K ﹤0.01%
+10,777
New +$103K
RLGT icon
2612
Radiant Logistics
RLGT
$395M
$62K ﹤0.01%
+10,800
New +$76K
SPRY icon
2613
ARS Pharmaceuticals
SPRY
$612M
$62K ﹤0.01%
11,600
-8,800
-43% -$43.4K
ABUS icon
2614
Arbutus Biopharma
ABUS
$915M
$61K ﹤0.01%
+31,900
New +$75.1K
CNVS icon
2615
Cineverse
CNVS
$65.6M
$61K ﹤0.01%
7,760
-35
-0.4% -$388
BNED icon
2616
Barnes & Noble Education
BNED
$443M
$60K ﹤0.01%
249
-45
-15% -$12K
CVM icon
2617
CEL-SCI Corp
CVM
$30.1M
$60K ﹤0.01%
647
-836
-56% -$101K
PMCB icon
2618
PharmaCyte Biotech
PMCB
$6.34M
$60K ﹤0.01%
24,800
-1,400
-5% -$3.54K
SVM
2619
Silvercorp Metals
SVM
$2.53B
$60K ﹤0.01%
25,900
+15,300
+144% +$36.8K
GPGI
2620
GPGI Inc
GPGI
$4.35B
$59K ﹤0.01%
14,087
+1,839
+15% +$8.62K
RTX icon
2621
CALL
RTX Corp
RTX
$301B
$59K ﹤0.01%
+50,000
New +$4.53M
MPU icon
2622
Mega Matrix
MPU
$13.7M
$58K ﹤0.01%
34,100
+200
+0.6% +$251
TNGX icon
2623
Tango Therapeutics
TNGX
$4.41B
$58K ﹤0.01%
+16,000
New +$68.3K
ADVM
2624
DELISTED
Adverum Biotechnologies
ADVM
$57K ﹤0.01%
6,000
RJET
2625
Republic Airways Holdings
RJET
$1B
$57K ﹤0.01%
2,320
-520
-18% -$17.8K

Similar funds

Schonfeld Strategic Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Schonfeld Strategic Advisors held 3,409 positions worth $11.9B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Schonfeld Strategic Advisors deployed $3.17B of net new capital in Q3 2022, opening 939 new positions and adding to 912 existing holdings. Its largest new stake was Corebridge Financial: 3,204,461 shares worth $63.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gen Digital, an estimated $94.3M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2022 buy was Corebridge Financial: 3,204,461 shares worth $63.1M.
  • Schonfeld Strategic Advisors added most to Fidelity National Information Services in Q3 2022, an estimated $94M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2022 reduction was Gen Digital, cutting an estimated $94.3M.
  • Schonfeld Strategic Advisors fully exited UMB Financial in Q3 2022, selling an estimated $33.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 6.6% of its $11.9B portfolio in Q3 2022.
  • Schonfeld Strategic Advisors opened 939 new positions and closed 491 in Q3 2022.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $11.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.